I would say directors positioning themselves, as the share price is very cheap in consideration of the company's financial position and their future projects.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025